{
    "Case ID": "040693",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent infringement dispute over manufacturing process"
    ],
    "Legal_Issue": [
        "Whether Apotex's process for manufacturing fluconazole infringes Pfizer's patent"
    ],
    "Governing_Law": [
        "Patent Act",
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Procedural_Stage": [
        "Federal Court litigation"
    ],
    "Evidence_Assessment": [
        "Expert testimony comparing chemical processes",
        "Analysis of intermediates and mechanisms",
        "Existence of Apotex’s separate patent"
    ],
    "Decision_Outcome": [
        "Application dismissed"
    ],
    "Burden_of_Proof": [
        "On Pfizer to demonstrate infringement"
    ],
    "Credibility_Factor": [
        "Expert evidence presented by both parties"
    ],
    "Legal_Rule": [
        "A patented process is infringed if another process is an 'obvious chemical equivalent'"
    ],
    "Standard_of_Review": [
        "Purposive construction of patent claims"
    ],
    "Procedural_Issue": [
        "Regulatory approval under NOC Regulations"
    ],
    "Grounds_for_Claim": [
        "Alleged functional similarity between Apotex's and Pfizer's processes"
    ],
    "Outcome_on_Merits": [
        "No infringement found"
    ],
    "Decision_Maker": [
        "Federal Court"
    ],
    "Judicial_Review_Outcome": [
        "Claim dismissed"
    ],
    "Review_Standard": [
        "Step-by-step comparison using purposive construction"
    ],
    "Procedural_Fairness_Assessment": [
        "Court conducted detailed analysis of expert testimonies and process steps"
    ],
    "Key_Evidence_Considered": [
        "Differences in chemical mechanisms",
        "Intermediates used",
        "Apotex’s independent patent"
    ],
    "Legal_Framework": [
        "Patent Act and NOC Regulations"
    ],
    "Applicant_Challenge": [
        "Pfizer sought to block Apotex’s regulatory approval"
    ],
    "Court_Result": [
        "Apotex can proceed with fluconazole production"
    ],
    "Legal_Rule_Source": [
        "Patent Act",
        "Regulations"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Denial of infringement, assertion of non-equivalent and non-obvious process"
    ],
    "Evidence_Type": [
        "Scientific expert testimony",
        "Process documentation",
        "Patent documents"
    ],
    "Remedy_Requested": [
        "Prevention of regulatory approval for Apotex’s fluconazole"
    ],
    "Outcome": [
        "No infringement; Apotex permitted to manufacture"
    ],
    "Decision_Authority": [
        "Federal Court of Canada"
    ],
    "Remedy_Sought": [
        "Injunction against regulatory approval"
    ],
    "Resolution_Mechanism": [
        "Judicial determination after trial"
    ],
    "Legal_Provision": [
        "Section of Patent Act relating to process patents",
        "Patented Medicines (NOC) Regulations"
    ],
    "Authority": [
        "Federal Court"
    ],
    "Claimant_Status": [
        "Pfizer as patent holder"
    ],
    "Legal_Provision_Cited": [
        "Patent Act",
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Lack of chemical equivalence",
        "Non-obviousness of Apotex’s process"
    ],
    "Applicable_Process": [
        "Notice of Compliance proceeding under PM(NOC) Regulations"
    ],
    "Outcome_of_Review": [
        "Apotex’s application allowed to proceed"
    ],
    "Pending_Relief_or_Application": [
        "Regulatory approval for generic fluconazole"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Purposive construction of patent claims to determine infringement"
    ]
}